WINNINGHAM RICK E (Chief Executive Officer) reported 2 transactions at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 6/17/2025ACC: 0001415889-25-017585
DirectorOfficer· Chief Executive Officer
Since Aug 2018
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
9.60K acquired · 9.60K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
−9.60K
Price / share
—
Trade value
—
% of position
0.5%
6/13/2025
1.76M→1.75M
Ordinary Shares
Indirect
Shares
+9.60K
Price / share
—
Trade value
—
% of position
246.2%
6/13/2025
3.90K→13.50K
Total
Net shares
+0.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/13/2025 | G · Gift | −9.60K | — | — | 0.5% | 1.76M | 1.75M |
| Ordinary Shares Indirect | 6/13/2025 | G · Gift | +9.60K | — | — | 246.2% | 3.90K | 13.50K |
| Total | +0.00 | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Ordinary Shares
IndirectShares owned92.57K
Total
92.57K indirect92.57K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 92.57K | Indirect |
| Total | 92.57K | 92.57K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported